These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4562825)

  • 1. Inhibition of tumor growth and survival of aged mice inoculated with Moloney tumor transplants and treated with endotoxin.
    Strausser HR; Bober LA
    Cancer Res; 1972 Oct; 32(10):2156-9. PubMed ID: 4562825
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract]   [Full Text] [Related]  

  • 3. Senescent loss of resistance to murine sarcoma virus (Moloney) in the mouse.
    Pazmiño NH; Yuhas JM
    Cancer Res; 1973 Nov; 33(11):2668-72. PubMed ID: 4748428
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
    Halliday WJ; Koppi TA; McKenzie IF
    J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the growth and regression of a transplantable Moloney sarcoma.
    Fefer A; McCoy JL; Glynn JP
    Cancer Res; 1967 Nov; 27(11):2207-11. PubMed ID: 4864248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors regulating the spontaneous regression of primary tumors induced by murine sarcoma virus, Moloney strain, in mice (BALB-c-Cb-Se). I. Age at treatment and virus doses].
    Ribacchi R; Giraldo G
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1967; 27(3):167-76. PubMed ID: 5605880
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective effect of immune sera against transplantable Moloney virus-induced sarcoma and lymphoma.
    Pearson GR; Redmon LW; Bass LR
    Cancer Res; 1973 Jan; 33(1):171-8. PubMed ID: 4734119
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines.
    Robey WG; Kuenzel WJ; Vande Woude GF; Fischinger PJ
    Cancer Res; 1982 Jul; 42(7):2523-9. PubMed ID: 6282443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of antilymphoma allograft reactivity by tumor-associated factors.
    Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
    Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
    [No Abstract]   [Full Text] [Related]  

  • 10. Biologic studies on hamster tumors induced by the murine sarcoma virus (Moloney).
    Perk K; Viola MV; Smith KL; Wivel NA; Moloney JB
    Cancer Res; 1969 May; 29(5):1089-102. PubMed ID: 4181060
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of a rhabdomyosarcoma (undifferentiated type) in rats induced by a murine sarcoma virus (Moloney).
    Perk K; Shachat DA; Moloney JB
    Cancer Res; 1968 Jun; 28(6):1197-206. PubMed ID: 5658448
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy and chemotherapy of Moloney sarcoma virus-induced tumors in mice.
    Fefer A
    Cancer Res; 1969 Dec; 29(12):2177-83. PubMed ID: 5369675
    [No Abstract]   [Full Text] [Related]  

  • 14. Stress and murine sarcoma virus (Moloney)-induced tumors.
    Amkraut A; Solomon GF
    Cancer Res; 1972 Jul; 32(7):1428-33. PubMed ID: 4337829
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus.
    Turner W; Chirigos MA
    Cancer Res; 1969 Nov; 29(11):1956-60. PubMed ID: 5358213
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The age related responses of New Zealand mice to a murine sarcoma virus.
    Gazdar AF; Beitzel W; Talal N
    Clin Exp Immunol; 1971 Mar; 8(3):501-9. PubMed ID: 5576664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour regression and relapse in mice inoculated with murine sarcoma virus (Moloney).
    Perk K; Russell E; Smith KL; Moloney JB
    Lab Anim; 1973 Sep; 7(3):255-63. PubMed ID: 4795193
    [No Abstract]   [Full Text] [Related]  

  • 20. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.